Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The distal human intestine harbors trillions of microbes that allow us to extract calories from otherwise indigestible dietary polysaccharides. The products of polysaccharide fermentation include short-chain fatty acids that are ligands for Gpr41, a G protein-coupled receptor expressed by a subset of enteroendocrine cells in the gut epithelium. To examine the contribution of Gpr41 to energy balance, we compared Gpr41 −/− and Gpr41 +/+ mice that were either conventionally-raised with a complete gut microbiota or were reared germ-free and then cocolonized as young adults with two prominent members of the human distal gut microbial community: the saccharolytic bacterium, Bacteroides thetaiotaomicron and the methanogenic archaeon, Methanobrevibacter smithii . Both conventionally-raised and gnotobiotic Gpr41 −/− mice colonized with the model fermentative community are significantly leaner and weigh less than their WT (+/+) littermates, despite similar levels of chow consumption. These differences are not evident when germ-free WT and germ-free Gpr41 knockout animals are compared. Functional genomic, biochemical, and physiologic studies of germ-free and cocolonized Gpr41 −/− and +/+ littermates disclosed that Gpr41-deficiency is associated with reduced expression of PYY, an enteroendocrine cell-derived hormone that normally inhibits gut motility, increased intestinal transit rate, and reduced harvest of energy (short-chain fatty acids) from the diet. These results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [57]
In the citing paper
“indigestible carbohydrates in the diet are fermented by the intestinal microbiota to produce short-chain fatty acids, which regulate immune function54, 55, intestinal hormone production, and lipogenesis56.”
From Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease (2014) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“In addition, colonization of adult GF mice, fed a standard polysacchariderich chow diet, with two organisms—Bacteroides thetaiotaomicron, a prominent saccharolytic bacterium in the normal distal human gut microbiota and an adept adaptive forager of polysaccharides (6), plus Methanobrevibacter smithii, a dominant metha…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Adult germ-free (GF) mice are leaner than their age- and gender-matched conventionally raised (CONV-R) counterparts who have acquired a microbiota beginning at birth (1).”
BackgroundSelf-citationTurnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 1×
“Locomotor activity and body temperature were assessed for 5 d using a telemetry device (minimitter PDT-4000; Mini Mitter) beginning 7 d after implantation (20).”
MethodSelf-citationBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., & White, B. A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1817 · Cited by 1,711 · cited 1×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundLe Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Cited by
Items 401–500 of 1,001
Safavi, M., Farajian, S., Kelishadi, R., Mirlohi, M., & Hashemipour, M. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.775224 · Cited by 117
“One pathway to help the host to harvest energy from food is by processing indigestible polysaccharides to short chain fatty acids, which are an important energy source for our body; also short chain fatty acids influence the gut motility and intestinal transit rate (Samuel et al., 2008).”
BackgroundThe power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer
Parida, S., & Sharma, D. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.001 · Cited by 116
Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases
Hirschberg, S., Gisevius, B., Duscha, A., & Haghikia, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123109 · Cited by 117
Hsu, Y.-J., Huang, W.-C., Lin, J.-S., Chen, Y.-M., Ho, S.-T., Huang, C.-C., & Tung, Y.-T. (2018) · Nutrients · doi:10.3390/nu10070862 · Cited by 116
Metabolic tinkering by the gut microbiome: Implications for brain development and function
Selkrig, J., Wong, P., Zhang, X., & Pettersson, S. (2014) · Gut Microbes · doi:10.4161/gmic.28681 · Cited by 116
Impact of early gut microbiota on immune and metabolic development and function
Wang, M., Monaco, M. H., & Donovan, S. M. (2016) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2016.04.004 · Cited by 138
Diet Effects in Gut Microbiome and Obesity
Chen, J., He, X., & Huang, J. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12397 · Cited by 114
Patrone, V., Vajana, E., Minuti, A., Callegari, M. L., Federico, A., Loguercio, C., Dallio, M., Tolone, S., Docimo, L., & Morelli, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00200 · Cited by 114
“…positive association with glucose (B = 0.360 and 0.347, respectively, with associated P = 0.0021 and 0.0079, respectively), thus showing a simultaneous independent effect on blood glucose concentration; while, there was no significant association in the last model (B = 0.035, P = 0.7066).”
BackgroundResultInfluentialIntestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Covasa, M., Stephens, R. W., Toderean, R., & Cobuz, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00082 · Cited by 112
“This was demonstrated in gnotobiotic models (128) where germ-free mice were colonized with a fermentative community composed of Bacteroides thetaiotaomicron and Methanobrevibacter smithii.”
BackgroundDiet and Inflammatory Bowel Disease.
Knight-Sepulveda, K., Kais, S., Santaolalla, R., & Abreu, M. T. (2015) · PubMed · Cited by 152
Chen, N., Zhang, H., Zong, X., Li, S., Wang, J., Wang, Y., & Jin, M. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116750 · Cited by 118
Zhong, M., Yan, Y., Yuan, H., Rong, A., Xu, G., Cai, F., Yang, Y., Wang, Y., & Zhang, W. (2022) · Food & Function · doi:10.1039/d2fo01009g · Cited by 120
Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
Luna‐Luna, M., Medina-Urrutia, A. X., Vargas‐Alarcón, G., Coss-Rovirosa, F., Vargas‐Barrón, J., & Pérez-Méndez, O. A. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.007 · Cited by 123
“Once absorbed, these carboxylic acids seem to exert complex metabolic functions influencing host hunger (167,168), intestinal transit time (167), absorption and energy harvest (169).”
BackgroundGut microbial metabolite short-chain fatty acids and obesity
LI, X., SHIMIZU, Y., & KIMURA, I. (2017) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.17-010 · Cited by 111
“Mechanistic studies revealed that activation of GPR41 on enteroendocrine cells stimulated secretion of the gut hormone peptide YY (PYY), which functions to induce satiety and reduce food intake [29], while SCFA-dependent GPR43 signaling was suggested to mediate host insulin sensitivity by promoting GLP-1 secretion [30…”
BackgroundPrattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 120
Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome
Hartstra, A. V., Schüppel, V., Imangaliyev, S., Schrantee, A., Prodan, A., Collard, D., Levin, E., Dallinga-Thie, G., Ackermans, M. T., Winkelmeijer, M., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101076 · Cited by 110
“It has also been shown to regulate hepatic lipogenesis and gluconeogenesis in mice on high-fat diets [40,41] and intestinal serotonin production [42,43], increasing SERT in the hypothalamus [44].”
BackgroundArora, T., & Sharma, R. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00365.x · Cited by 109
SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?
Priyadarshini, M., Wicksteed, B., Schiltz, G. E., Gilchrist, A., & Layden, B. T. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.03.011 · Cited by 110
“FFA3 signaling has also been implicated in modulating body fat mass, although these effects are also far from clear with reports of Ffar3 mice having no change [38], loss [43] or gain of body fat mass [44].”
Maternal short-chain fatty acids are associated with metabolic parameters in mothers and newborns
Priyadarshini, M., Thomas, A., Reisetter, A. C., Scholtens, D. M., Wolever, T. M. S., Josefson, J. L., & Layden, B. T. (2014) · Translational research · doi:10.1016/j.trsl.2014.01.012 · Cited by 117
The modulatory role of high fat feeding on gastrointestinal signals in obesity
Duca, F. A., Sakar, Y., & Covașă, M. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.05.005 · Cited by 127
“involved in PYY secretion [44], and GPR41 and GPR43 KOmice secrete less GLP-1, both in-vitro and in-vivo by SCFAs [55].”
BackgroundMicrobiota–Host Transgenomic Metabolism, Bioactive Molecules from the Inside: Miniperspective
Turroni, S., Brigidi, P., Cavalli, A., & Candela, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00244 · Cited by 108
He, J., Guo, H., Zheng, W., Xue, Y., Zhao, R., & Yao, W. (2019) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0391-0 · Cited by 120
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Wu, Y., Xu, H., Tu, X., & Gao, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.730809 · Cited by 123
Cook, T. M., Gavini, C. K., Jesse, J., Aubert, G., Gornick, E., Bonomo, R., Gautron, L., Layden, B. T., & Mansuy-Aubert, V. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101350 · Cited by 105
“found that global FFAR3KO decreased energy harvest (reduced caloric and SCFA absorption) and decreased adiposity [42].”
BackgroundGuerra, P. V. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3916 · Cited by 106
Gut Microbiota: A Contributing Factor to Obesity
Harakeh, S. M., Khan, I., Kumosani, T., Barbour, E., Almasaudi, S. B., Bahijri, S. M., Alfadul, S. M., Ajabnoor, G. M. A., & Azhar, E. I. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00095 · Cited by 107
“Studies showed that GLP2, a 33-amino acid peptide, may cause the GM to modulate the gut barrier and endotoxinemia and is known for its intestinotrophic properties (Samuel et al., 2008; De Silva and Bloom, 2012).”
BackgroundOnal, E. M., Afşar, B., Covic, A. C., Vaziri, N. D., & Kanbay, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0144-z · Cited by 121
Gao, H., Wen, J.-J., Hu, J., Nie, Q., Chen, H., Nie, S., Xiong, T., & Xie, M. (2019) · Food Bioscience · doi:10.1016/j.fbio.2019.03.007 · Cited by 111
Regulation of dietary fiber on intestinal microorganisms and its effects on animal health
Xue-bing, H., Ma, Y., Ding, S., Fang, J., & Liu, G. (2023) · Animal nutrition · doi:10.1016/j.aninu.2023.06.004 · Cited by 121
Degroote, S., Hunting, D. J., Baccarelli, A. A., & Takser, L. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.06.010 · Cited by 106
Wang, Y., Tang, C., Tang, Y., Yin, H., & Liu, X. (2020) · Food & Nutrition Research · doi:10.29219/fnr.v64.3525 · Cited by 112
“FFAR2 and FFAR3 co-localize with colonic L-cells and stimulate the release of peptide tyrosine (PYY), and glucagon-like peptide 1(GLP-1) (46, 47).”
BackgroundShort-Chain Fatty Acid Receptors and Cardiovascular Function
Lymperopoulos, A., Suster, M. S., & Borges, J. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063303 · Cited by 121
“Additionally, FFAR3 significantly reduces lipolysis by inhibiting hormonesensitive lipase phosphorylation and activity via Gαi-mediated AC inhibition and cAMP lowering in peripheral adipose tissues [15,94] and increases leptin production, hepatic lipogenesis, and adipocyte growth [4] (Figure 2).”
BackgroundAntibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract
Fenneman, A. C., Weidner, M., Chen, L. A., Nieuwdorp, M., & Blaser, M. J. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00685-9 · Cited by 116
Nutritional modulation of gut microbiota — the impact on metabolic disease pathophysiology
Ojeda, P., Bobe, A., Dolan, K., Leone, V., & Martinez, K. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.013 · Cited by 105
“Gpr41 promotes host adiposity and induction of peptide YY (PYY), a peptide hormone that slows gut motility and promotes satiety [23].”
BackgroundFree Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids
Rodríguez‐Carrio, J., Salazar, N., Margollés, A., González, S., Gueimonde, M., Reyes‐Gavilán, C. G. D. L., & Suárez, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00823 · Cited by 108
Dietary nutrition and gut microflora: A promising target for treating diseases
Nie, Y., Luo, F., & Lin, Q. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.03.002 · Cited by 111
Alessandro de, S. I. R. E., de Sire, R., Petito, V., Masi, L., Cisari, C., Gasbarrini, A., Scaldaferri, F., & Invernizzi, M. (2020) · Nutrients · doi:10.3390/nu12020574 · Cited by 123
Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites
Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 121
Cui, J., Ramesh, G., Wu, M., Jensen, E. T., Crago, O. L., Bertoni, A. G., Gao, C., Hoffman, K. L., Sheridan, P. A., Wong, K. E., et al. (2022) · Diabetes · doi:10.2337/db22-0168 · Cited by 119
Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders
Sankararaman, S., Noriega, K. J., Velayuthan, S., Sferra, T. J., & Martindale, R. G. (2022) · Current Gastroenterology Reports · doi:10.1007/s11894-022-00859-0 · Cited by 120
Free Fatty Acids-Sensing G Protein-Coupled Receptors in Drug Targeting and Therapeutics
Yonezawa, T., Kurata, R., Yoshida, K., Murayama, M., Cui, X., & Hasegawa, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990168 · Cited by 103
“demonstrated that in CONV-R and gnotobiotic mice possessing Bacteroides theaiotaomicron and Methanobrevibacter smithii, GPR41 deficiency induces significantly leaner mice that less than wild type although the differences are not observed in a germ-free condition [104] (Fig.”
BackgroundLau, H. C.-H., Zhang, X., & Yu, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01089-1 · Cited by 138
“On the other hand, ablation of G protein-coupled receptor 41 (GPR41) and GPR43, the two dominant hepatocytic SCFA receptors, improves energy expenditure and reduces adiposity and hepatic triglycerides in HFD-fed mice 120,121 .”
Marques, T. M., Wall, R., O'Sullivan, O., Fitzgerald, G. F., Shanahan, F., Quigley, E. M., Cotter, P. D., Cryan, J. F., Dinan, T. G., Ross, R. P., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514004206 · Cited by 102
Ripened Pu-erh Tea Extract Protects Mice from Obesity by Modulating Gut Microbiota Composition
Lu, X., Liu, J., Zhang, N., Fu, Y., Zhang, Z., Li, Y., Wang, W., Li, Y., Shen, P. F., & Cao, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b04909 · Cited by 110
Zhang, J.-M., Sun, Y.-S., Zhao, L.-Q., Chen, T.-T., Fan, M.-N., Jiao, H., Zhao, J.-P., Wang, X.-J., Li, F.-C., Li, H.-F., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02176 · Cited by 112
“(f) Exendin(9-39)(Exd) recovered TG content Primary hepatocytes; (g) Exendin(9-39) inhibited the phosphorylation of AMK in primary hepatocytes (n=6).”
BackgroundObesity, Metabolic Syndrome, and Microbiota: Multiple Interactions
Tilg, H. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dd8b64 · Cited by 101
“These studies showed that Gpr41 might be a regulator of host energy balance through effects that are dependent on the gut microbiota and their metabolic capacity.(13) It has been suggested that the regulation of PYY, an enteroendocrine cell-derived hormone that normally inhibits gut motility and fastens intestinal tra…”
BackgroundUdayappan, S. D., Hartstra, A. V., Dallinga-Thie, G. M., & Nieuwdorp, M. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12293 · Cited by 101
Guo, X., Liu, S., Wang, Z., Zhang, X., Li, M., & Wu, B. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.03.068 · Cited by 107
“Further, based on previous reports, some abundant genera are linked with these host-gut co-metabolites (Ridlon et al., 2006; Samuel et al., 2008; Swann et al., 2011).”
Microbial Metabolites: Critical Regulators in NAFLD
Dai, X., Hou, H., Zhang, W., Liu, T., Li, Y., Wang, S., Wang, B., & Cao, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.567654 · Cited by 111
“SCFAs activate the G-proteincoupled receptors (GPCRs) GPR41, GPR43, and GPR109A, which are expressed on adipocytes, hepatic cells, and colonic cells (Samuel et al., 2008; Maslowski et al., 2009; Singh et al., 2014).”
BackgroundGut microbiota, nutrient sensing and energy balance
Duca, F. A., & Lam, T. K. T. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12340 · Cited by 100
“Specifically, SCFA production is associated with increased GLP-1 and PYY production, possibly mediated through GPR41 [69].”
BackgroundInfluentialXue, B., Xie, J., Huang, J., Chen, L., Gao, L., Ou, S., Wang, Y., & Peng, X. (2016) · Food & Function · doi:10.1039/c5fo01438g · Cited by 100
Park, Y. M., Lee, S.-Y., Kang, M.-J., Kim, B.-S., Lee, M.-J., Jung, S. S., Yoon, J. S., Cho, H.-J., Lee, E., Yang, S.-I., et al. (2020) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2020.12.2.322 · Cited by 99
Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Lee, Y. A., & Friedman, S. L. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13380 · Cited by 108
The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology
Guo, Y., Chen, X., Gong, P., Li, G., Yao, W., & Yang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044089 · Cited by 114
Identification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes
Wang, A., Gu, Z., Heid, B., Akers, R. M., & Jiang, H. (2009) · Journal of Dairy Science · doi:10.3168/jds.2009-2037 · Cited by 98
“…fatty acids on leptin production in adipocytes (Xiong et al., 2004) and the effect of gut microbiota on host energy balance and adiposity (Samuel et al., 2008), and GPR43 was shown to mediate the stimulatory effect of short-chain fatty acids on adipogenesis (Hong et al., 2005) and…”
Raka, F., Farr, S., Kelly, J., Stoianov, A. M., & Adeli, K. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00036.2019 · Cited by 108
The microbiota–microglia axis in central nervous system disorders
Mossad, O., & Erny, D. (2020) · Brain Pathology · doi:10.1111/bpa.12908 · Cited by 98
“SCFAs, mainly comprised of acetate, propionate, and butyrate, function through either G-protein-coupled receptors (GPCRs) or histone deacetylases (HDACs) (36, 37).”
BackgroundLee, M., Hsu, Y.-J., Ho, H.-H., Hsieh, S., Kuo, Y., Sung, H., & Huang, C. (2020) · Microorganisms · doi:10.3390/microorganisms8040545 · Cited by 109
Duca, F. A., Swartz, T. D., Sakar, Y., & Covașă, M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.45 · Cited by 111
Gut microbiota in health and disease: an overview focused on metabolic inflammation
Nagpal, R., Kumar, M., Yadav, A. K., Hemalatha, R., Yadav, H., Marotta, F., & Yamashiro, Y. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0062 · Cited by 97
“Following ligand binding, these receptors can promote the secretion of gut hormone pancreatic peptide YY (PYY) which may further slowdown the gut motility and the intestinal transit, thereby leading to an increased nutrient absorption (Samuel et al., 2008).”
BackgroundRole of the gut in visceral fat inflammation and metabolic disorders
Lam, Y. Y., Mitchell, A. J., Holmes, A. J., Denyer, G. S., Gummesson, A., Caterson, I. D., Hunt, N. H., & Storlien, L. H. (2011) · Obesity · doi:10.1038/oby.2011.68 · Cited by 97
“Whereas butyrate is mainly used as an energy source for colonic epithelial cells, acetate and propionate are delivered to the liver for de novo lipogenesis (91).”
BackgroundObesity and the gut microbiome: Striving for causality
Harley, I. T. W., & Karp, C. L. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.07.002 · Cited by 96
“Nonetheless, increased weight gain has been reported after reductive colonization of germ-free mice with a two species system consisting of Bacteroides thetaiotamicron and Methanobrevibacter smithii [109,110], something that may well be a function of total intestinal bacterial load, as mice colonized with both B.”
BackgroundInfluentialA review on gut microbiota: a central factor in the pathophysiology of obesity
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01491-z · Cited by 95
The pathophysiology of MASLD: an immunometabolic perspective
Schwärzler, J., Grabherr, F., Grander, C., Adolph, T. E., & Tilg, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2294046 · Cited by 117
“…ameliorate diet-induced steatosis and hepatic inflammation in mice [76,77], possibly by reducing fat accumulation in the adipose tissue, which reduces FFA-release to the blood, but also by protecting the gut barrier [78] or regulating intestinal motility and thereby intestinal transit time [79].”
Role of gut microbiota in the control of energy and carbohydrate metabolism
Venema, K. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833a8b60 · Cited by 97
Zhou, H. W., Yu, B., Sun, J., Liu, Z., Chen, H., Ge, L., & Chen, D. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00581-3 · Cited by 109
“G-protein-coupled receptors (GPRs), GPR41 and GPR43 have been demonstrated to be indispensable for a range of SCFA-mediated effects [59, 60].”
BackgroundSteinert, R. E., & Beglinger, C. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.039 · Cited by 116
Holmes, Z. C., Silverman, J. D., Dressman, H. K., Wei, Z., Dallow, E. P., Armstrong, S., Seed, P. C., Rawls, J. F., & David, L. A. (2020) · mBio · doi:10.1128/mbio.00914-20 · Cited by 115
“decreasing adipogenesis (12, 23, 62); yet, we did not observe associations between”
Modulation of Adipocyte Metabolism by Microbial Short-Chain Fatty Acids
May, K. S., & den Hartigh, L. J. (2021) · Nutrients · doi:10.3390/nu13103666 · Cited by 107
Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology
May, K. S., & den Hartigh, L. J. (2023) · Nutrients · doi:10.3390/nu15020272 · Cited by 95
Understanding the role of gut microbes and probiotics in obesity: How far are we?
Sanz, Y., Rastmanesh, R., & Agostoni, C. V. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.021 · Cited by 103
Parekh, P. J., Arusi, E., Vinik, A. I., & Johnson, D. A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00047 · Cited by 94
“evaluated the effect of gut microbiota on adiposity by observing mice deficient in FFAR3 (Gpr41−/−) in comparison to wild-type (Grp41+/+) (20).”
BackgroundHoughton, D., Hardy, T., Stewart, C., Errington, L., Day, C. P., Trenell, M. I., & Avery, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4632-0 · Cited by 94
“Potential mechanisms include: (1) altered levels of glucagon-like peptide-1 and -2 [15]; (2) increased lipopolysaccharides; (3) inflammation [18]; (4) reduced SCFAs and appetite [46]; and (5) increased energy extraction from digesta [12].”
BackgroundGut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 98
“In mice, decreased expression of PYY resulting from Gpr41 deficiency and suppression of insulin signaling due to Gpr43 deletion are both gut microbiota dependent.(146,147) In adipose tissue and liver, SCFAs promote fat oxidation via AMPK in a PPARγ‐dependent manner.”
BackgroundMicrobial metabolites in non-alcoholic fatty liver disease
Zhou, D., & Fan, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2019 · Cited by 105
Chen, R., Wang, J., Zhan, R., Zhang, L., & Wang, X. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112139 · Cited by 105
The effects of gut microbiota on appetite regulation and the underlying mechanisms
Yu, M., Yu, B., & Chen, D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2414796 · Cited by 118
Molecular Basis of Health and Disease
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4 · Cited by 103
Tribe, R. M., Taylor, P. D., Kelly, N. M., Rees, D., Sandall, J., & Kennedy, H. P. (2018) · The Journal of Physiology · doi:10.1113/jp275429 · Cited by 92
The Metabolic Role and Therapeutic Potential of the Microbiome
Olofsson, L. E., & Bäckhed, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac004 · Cited by 92
Regulation of Energy Homeostasis by GPR41
Inoue, D., Tsujimoto, G., & Kimura, I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00081 · Cited by 93
“Samuel and colleagues (15) showed that co-colonization of human gutderived microbiota in germ-free mice led to significantly increased circulating levels of PYY, which suppresses gut motility.”
BackgroundMethodInfluentialNi, Y., Ni, L., Zhuge, F., Xu, L., Fu, Z., & Ota, T. (2020) · Obesity · doi:10.1002/oby.22674 · Cited by 101
“SCFAs are vital meditators of fat accumulation in adipocytes via receptor activation through G-protein-coupled receptor (GPR)43 and GPR41 (42), which are expressed primarily on adipocytes and immune cells (Figure 2A).”
BackgroundSaji, N., Murotani, K., Hisada, T., Kunihiro, T., Tsuduki, T., Sugimoto, T., Kimura, A., Niida, S., Toba, K., & Sakurai, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-65196-6 · Cited by 90
Ullmer, C., Alvarez Sanchez, R., Sprecher, U., Raab, S., Mattei, P., Dehmlow, H., Sewing, S., Iglesias, A., Beauchamp, J., & Conde‐Knape, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12158 · Cited by 92
Pharmacology and physiology of gastrointestinal enteroendocrine cells
Mace, O. J., Tehan, B., & Marshall, F. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.155 · Cited by 91
“The enteroendocrine system is also adjusted for the microbial population of the large intestine, that plays a central role in whole body metabolic status (Backhed et al. 2004; Ley et al. 2006; Turnbaugh et al. 2006; Samuel et al. 2008; Cani et al. 2009; Ridaura et al. 2013).”
BackgroundThe Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
You, H., Tan, Y., Yu, D., Qiu, S., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.886902 · Cited by 105
Sommer, F., & Bäckhed, F. (2016) · BioEssays · doi:10.1002/bies.201500151 · Cited by 91
Human Gut Microbiota in Health and Alzheimer’s Disease
Szablewski, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170908 · Cited by 91
“They are ligands for two receptors of endocrine cells in gut: G-protein-coupled receptor 41 (GPR41) and G-protein-coupled receptor 43 (GPR43) [68, 69].”
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 95
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Smirne, C., Croce, E., Benedetto, D. D., Cantaluppi, V., Comi, C., Sainaghi, P. P., Minisini, R., Grossini, E., & Pirisi, M. (2022) · Livers · doi:10.3390/livers2010003 · Cited by 111
Coordinated regulation of the metabolome and lipidome at the host-microbial interface
Bäckhed, F., & Crawford, P. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.009 · Cited by 90
“This may in part be explained by the ability of the microbiota to increase gut transit time [54,55], which could compensate for relatively reduced absorption rates compared to GF mice.”
BackgroundMicrobiomes, metagenomics, and primate conservation: New strategies, tools, and applications
Stumpf, R. M., Gomez, A. M., Amato, K. R., Yeoman, C. J., Polk, J. D., Wilson, B. A., Nelson, K. E., White, B. A., & Leigh, S. R. (2016) · Biological Conservation · doi:10.1016/j.biocon.2016.03.035 · Cited by 99
Intestinal Microbiota and Obesity
Blaut, M., & Klaus, S. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_11 · Cited by 107
Gong, J., & Yang, C. (2012) · Food Research International · doi:10.1016/j.foodres.2011.12.027 · Cited by 104
Oh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
Gut-Brain Axis in the Early Postnatal Years of Life: A Developmental Perspective
Jena, A., Montoya, C. A., Mullaney, J. A., Dilger, R. N., Young, W., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00044 · Cited by 107
“…coexpressed SCFA receptors like free fatty acid receptor 2 and 3 (Karaki et al., 2008; Tolhurst et al., 2012), and deletion of these SCFA receptors in EEC in a mouse model has resulted in impaired PYY expression (Samuel et al., 2008) and reduced GLP-1 blood concentration (Tolhurst et al., 2012).”
BackgroundVeprik, A., Laufer, D., Weiss, S., Rubins, N., & Walker, M. D. (2016) · The FASEB Journal · doi:10.1096/fj.201500030r · Cited by 88
“In accordance with previous results (11, 20, 21), GPR41 mRNA was detected at its highest levels in pancreatic islets and the duodenum.”
ResultGut microbiota regulates key modulators of social behavior
Parashar, A., & Udayabanu, M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.002 · Cited by 88
Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
Watterson, K. R., Hudson, B. D., Ulven, T., & Milligan, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00137 · Cited by 97
Protective Effects of Anthocyanins in Obesity‐Associated Inflammation and Changes in Gut Microbiome
Jayarathne, S., Stull, A. J., Park, O., Kim, J. H., Thompson, L., & Moustaïd‐Moussa, N. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900149 · Cited by 94
Metadata
- Authors
- Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., & Gordon, J. I.
- Affiliations
- Washington University in St. Louis (US)
- The University of Texas Southwestern Medical Center (US)
- Japan Science and Technology Agency (JP)
- *Center for Genome Sciences and
- Howard Hughes Medical Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-10-28
- Volume
- 105
- Issue
- 43
- Pages
- 16767-16772
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2569967
- OpenAlex
- W2142336938
- Cited by
- 1,564
- References
- 23
- Citations by year
- 2026: 51 · 2025: 83 · 2024: 71 · 2023: 93 · 2022: 110 · 2021: 137 · 2020: 127 · 2019: 110 · 2018: 107 · 2017: 104 · 2016: 110 · 2015: 87 · 2014: 88 · 2013: 80 · 2012: 70
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK030292, DK-30292, DK 70977, R01DK070977, P30DK056341, R01DK030292)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- GPR41, gut microbiota, adiposity, short-chain fatty acids, energy balance, Bacteroides thetaiotaomicron, Methanobrevibacter smithii, peptide YY, enteroendocrine cells, intestinal transit, gnotobiotic mice, germ-free mice, polysaccharide fermentation, host-microbe interactions
- MeSH terms
- Animals, Bacteroides, Energy Metabolism, Germ-Free Life, Humans, Symbiosis, Mice, Knockout, Peptide YY, Methanobrevibacter, Gastrointestinal Tract, Receptors, G-Protein-Coupled, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.